Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - The Cognitive Cost of Anticholinergic Burden: Decreased Response to Cognitive Training in Schizophrenia

Sophia Vinogradov, Melissa Fisher, Heather Warm, Christine Holland, Margaret A. Kirshner, and Bruce G. Pollock

Am J Psychiatry Published July 1, 2009

3! - Prevalence of alcohol use disorders in schizophrenia – a systematic review and meta-analysis

J. Koskinen, J. Löhönen, H. Koponen, M. Isohanni, J. Miettunen

Acta Psychiatrica Scandinavica. Volume 120 Issue 2, Pages 85 - 96

 

3 - Risperidone long-acting injection: a 6-year mirror-image study of healthcare resource use

D. Taylor, C. Fischetti, A. Sparshatt, A. Thomas, D. Bishara, V. Cornelius

Acta Psychiatrica Scandinavica. Volume 120 Issue 2, Pages 97 - 101

 

3! - How psychiatrists inform themselves and their patients about risks and benefits of antipsychotic treatment

R. Mendel, J. Hamann, E. Traut-Mattausch, E. Jonas, S. Heres, D. Frey, W. Kissling

Acta Psychiatrica Scandinavica. Volume 120 Issue 2, Pages 112 - 119

 

3 - Achieving symptomatic remission in out-patients with schizophrenia – a naturalistic study with quetiapine

T. Wobrock, J. Köhler, P. Klein, P. Falkai

Acta Psychiatrica Scandinavica. Volume 120 Issue 2, Pages 120 - 128

 

3 - A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis

N. M. Menezes, A. M. Malla, R. M. Norman, S. Archie, P. Roy, R. B. Zipursky

Acta Psychiatrica Scandinavica. Volume 120 Issue 2, Pages 138 - 146

 

3 - HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patientsOriginal Investigation

Shih-Fen Chen, Yu-Chih Shen and Chia-Hsiang Chen

Psychopharmacology. Volume 205, Number 2 / August, 2009: 285-292

 

3 - Intervention in Individuals at Ultra High Risk for Psychosis: A Review and Future Directions

Patrick D. McGorry, Barnaby Nelson, G. Paul Amminger, Andreas Bechdolf, Shona M. Francey, Gregor Berger, Anita Riecher-Rössler, Joachim Klosterkötter, Stephan Ruhrmann, Frauke Schultze-Lutter, Merete Nordentoft, Ian Hickie, Philip McGuire, Michael Berk, Eric Y. H. Chen, Matcheri S. Keshavan, and Alison R. Yung

J Clin Psychiatry June 30, 2009: e1-e7

 

3< - Effects of Quetiapine on Cognitive Functions in Schizophrenic Patients: A Preliminary Single-trial ERP Analysis

Y. Zhang, M. Lehmann, A. Shobeiry, D. Höfer, S. Johannes, H. M. Emrich, D. E. Dietrich

Pharmacopsychiatry 2009; 42: 129-134

3 - Reasons and Outcomes of Olanzapine Dose Adjustments in the Outpatient Treatment of Schizophrenia

D. Suarez, J. M. Haro, D. Novick, E. Perrin, S. Ochoa, D. Naber

Pharmacopsychiatry 2009; 42: 135-140

 

3 - The Effects of Paroxetine on the Pharmacokinetics of Paliperidone Extended-release Tablets

J. Berwaerts, A. Cleton, V. Herben, I. van de Vliet, I. Chang, P. van Hoek, M. Eerdekens

Pharmacopsychiatry 2009; 42: 158-163

 

3! - Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?

Leslie Citrome and Joshua T Kantrowitz

Expert Review of Neurotherapeutics. July 2009, Vol. 9, No. 7, Pages 1045-1058

 

3! - Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)

J.M. Olivares, A. Rodriguez-Morales, J. Diels, M. Povey, A. Jacobs, Z. Zhao and A. Lam

European Psychiatry. Volume 24, Issue 5, June 2009, Pages 287-296

 

3 - Effect of Food on the Pharmacokinetics of Clozapine Orally Disintegrating Tablet 12.5 mg: A Randomized, Open-Label, Crossover Study in Healthy Male Subjects

DiSanto, Anthony R; Golden, Gil

Clinical Drug Investigation. 29(8):539-549, August 8, 2009

3! - Influence of antipsychotics on mortality in schizophrenia: Systematic review

Stefan Weinmann, John Read and Volkmar Aderhold

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 1-11

 

3! - Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial

Robert A. Rosenheck, Vicki G. Davis, Sonia M. Davis, Scott Stroup, Joseph McEvoy, Marvin Swartz and Jeffrey Lieberman

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 12-18

 

5 - Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study

Edgardo Carrizo, Virginia Fernández, Lisette Connell, Ignacio Sandia, Dexy Prieto, Johana Mogollón, Dennys Valbuena, Iliana Fernández, Enma Araujo de Baptista and Trino Baptista

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 19-26

 

3 - Optimal thresholds of early response to atypical antipsychotics: Application of signal detection methods

Lei Chen, Haya Ascher-Svanum, Virginia Stauffer, Bruce J. Kinon, Sara Kollack-Walker and Stephen Ruberg

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 34-40

 

5 - A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study

J. Karagianis, L. Grossman, J. Landry, V.A. Reed, L. de Haan, G.A. Maguire, V.P. Hoffmann and R. Milev

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 41-48

 

4 - Effectiveness of second-generation antipsychotics with acute-phase schizophrenia

Kotaro Hatta, Koji Sato, Hiroshi Hamakawa, Hiroshi Takebayashi, Naoto Kimura, Shinichiro Ochi, Yasuhiko Sudo, Nozomu Asukai, Hiroyuki Nakamura, Chie Usui, Toshitaka Kawabata, Toyoaki Hirata and Yutaka Sawa

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 49-55

 

4 - Paliperidone extended-release for schizophrenia: Effects on symptoms and functioning in acutely ill patients with negative symptoms

C.M. Canuso, C.A. Bossie, I. Turkoz and L. Alphs

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 56-64

3 - Pituitary volume and early treatment response in drug-naïve first-episode psychosis patients

B. Garner, G.E. Berger, J.P. Nicolo, A. Mackinnon, S.J. Wood, C.M. Pariante, P. Dazzan, T.M. Proffitt, C. Markulev, M. Kerr, M. McConchie, L.J. Phillips, C. Pantelis and P.D. McGorry

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 65-71

 

3 - Effect of risperidone on emotion recognition deficits in antipsychotic-naïve schizophrenia: A short-term follow-up study

Rishikesh V. Behere,Ganesan Venkatasubramanian, Rashmi Arasappa, Nalini Reddy and Bangalore N. Gangadhar

Schizophrenia Research. Volume 113, Issue 1, August 2009, Pages 72-76

 

3! - ABCB1 and Cytochrome P450 Polymorphisms: Clinical Pharmacogenetics of Clozapine

Jaquenoud Sirot, Eveline; Knezevic, Branka; Morena, Gina Perla; Harenberg, Sabine; Oneda, Beatrice; Crettol, Séverine; Ansermot, Nicolas; Baumann, Pierre; Eap, Chin B

Journal of Clinical Psychopharmacology: August 2009 - Volume 29 - Issue 4 - pp 319-326

 

3 - Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects

Mei Han, Xu-Feng Huang and Chao Deng

The International Journal of Neuropsychopharmacology (2009), 12:941-952

 

GRATIS 3! - Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy

Ilya A Lipkovich, Walter Deberdt, John G Csernansky, Bernard Sabbe, Richard SE Keefe and Sara Kollack-Walker

BMC Psychiatry 2009, 9:44

 

3! - The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians

Naber, Dieter; Lambert, Martin

CNS Drugs. 23(8):649-659, August 8, 2009

3 - Patients' Attitudes towards Generic Substitution of Oral Atypical Antipsychotics: A Questionnaire-Based Survey in a Hypothetical Pharmacy Setting

Roman, Beatriz

CNS Drugs. 23(8):693-701, August 8, 2009

3 - Atypical antipsychotics as noncompetitive inhibitors of α4β2 and α7 neuronal nicotinic receptors

Vladimir P. Grinevich, Roger L. Papke, Patrick M. Lippiello and Merouane Bencherif

Neuropharmacology. Volume 57, Issue 2, August 2009, Pages 183-191

3! - Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia

Taryn G. Moss, Kristi A. Sacco, Taryn M. Allen, Andrea H. Weinberger, Jennifer C. Vessicchio and Tony P. George

Drug and Alcohol Dependence. Volume 104, Issues 1-2, 1 September 2009, Pages 94-99

 

3! - Dopamine D_2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine

Heli Tuppurainen, Jyrki T. Kuikka, Heimo Viinamäki, Minna Husso, and Jari Tiihonen

Psychiatry and Clinical Neurosciences. Volume 63 Issue 4, Pages 529 - 537

 

3 - Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders

Ying-Ching Lai, Ming-Chyi Huang, Chun-Hsin Chen, Chang-Jer Tsai, Chun-Hung Pan, and Chih-Chiang Chiu

Psychiatry and Clinical Neurosciences. Volume 63 Issue 4, Pages 440 - 448

 

3! - Dosing of antipsychotics in schizophrenia across the life-spectrum

Hiroyuki Uchida and David C. Mamo

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 6, 31 August 2009, Pages 917-920

3! - Differential pattern of heart rate variability in patients with schizophrenia

Jae Seung Chang, Cheol Sung Yoo, Sang Hoon Yi, Kye Hyun Hong, Hong Seok Oh, Jae Youn Hwang, Su-Gyeong Kim, Yong Min Ahn and Yong Sik Kim

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 6, 31 August 2009, Pages 991-995

3! - Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain

Giuseppe Tringali, Lucia Lisi, Maria Laura De Simone, Jean-Michel Aubry, Paolo Preziosi, Giacomo Pozzoli and Pierluigi Navarra

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 6, 31 August 2009, Pages 1017-1021

 

5 - Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia

David Hough, Jean-Pierre Lindenmayer, Srihari Gopal, Rama Melkote, Pilar Lim, Virginie Herben, Eric Yuen and Marielle Eerdekens

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 6, 31 August 2009, Pages 1022-1031

 

3 - The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment. Curaçao extrapyramidal syndromes study IX

B Wilffert, AFY Al Hadithy, VJ Sing, G Matroos, HW Hoek, J van Os, R Bruggeman, JRBJ Brouwers, PN van Harten

J Psychopharmacol 2009 23: 652-659

 

3 - Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia

RJ Hempel, JHM Tulen, NJM van Beveren, CH Röder, MW Hengeveld

Journal of Psychopharmacology, Vol. 23, No. 6, 697-707 (2009)

 

3! - Waist Circumference is the Best Anthropometric Predictor for Insulin Resistance in Nondiabetic Patients with Schizophrenia Treated with Clozapine but not Olanzapine

Henderson, David C; Fan, Xiaoduo; Sharma, Bikash; Copeland, Paul M; Borba, Christina P.C; Freudenreich, Oliver; Cather, Corinne; Evins, A. Eden; Goff, Donald C

Journal of Psychiatric Practice: July 2009 - Volume 15 - Issue 4 - pp 251-261

 

3! - Antipsychotic Drugs and Hyperglycemia in Older Patients With Diabetes

Lorraine L. Lipscombe, Linda Lévesque, Andrea Gruneir, Hadas D. Fischer, David N. Juurlink, Sudeep S. Gill, Nathan Herrmann, Janet E. Hux, Geoff M. Anderson, Paula A. Rochon

Arch Intern Med. 2009;169(14):1282-1289

 

3 - Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

Jean-Pierre Lindenmayer, Hong Liu-Seifert, Pandurang M. Kulkarni, Bruce J. Kinon, Virginia Stauffer, Sara E. Edwards, Lei Chen, David H. Adams, Haya Ascher-Svanum, Peter F. Buckley, Leslie Citrome, and Jan Volavka

J Clin Psychiatry 2009;70(7):990–996

 

3! - Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis

Swapna K. Verma, Mythily Subramaniam, Alvin Liew, and Lye Yin Poon

J Clin Psychiatry 2009;70(7):997–1000

 

3 - Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent? A Literature Review

Viktoria Simon, Ruud van Winkel, and Marc De Hert

J Clin Psychiatry 2009;70(7):1041–1050

 

GRATIS 3 - Psicosis de base somática

Norma Derito, Gabriela Martínez, Alberto Monchablon Espinoza

Alcmeon, vol. 15, Nº 4, julio de 2009, págs. 223 a 267

 

3! - First Episode Psychosis, Substance Abuse and Prognosis: A Systematic Review

Suzanne Archie and Katalin Gyömörey

.

Regresar a RESÚMENES JULIO 2009